EP Patent

EP1262198A1 — Composition with sustained release of levodopa and carbidopa

Assigned to Acino Holding AG · Expires 2002-12-04 · 23y expired

What this patent protects

The invention relates to a pharmaceutical composition comprising a therapeutically effective amount of levodopa and of carbidopa, dispersed in a hydrophilic matrix, said composition further comprising an organic acid. A subject of the invention is also a process for prepari…

USPTO Abstract

The invention relates to a pharmaceutical composition comprising a therapeutically effective amount of levodopa and of carbidopa, dispersed in a hydrophilic matrix, said composition further comprising an organic acid. A subject of the invention is also a process for preparing the composition, comprising granulation, in particular in a fluidized bed, of the various components and compression of the granules obtained.

Drugs covered by this patent

Patent Metadata

Patent number
EP1262198A1
Jurisdiction
EP
Classification
—
Expires
2002-12-04
Drug substance claim
No
Drug product claim
No
Assignee
Acino Holding AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.